Lincoln National Corp lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 1.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,580 shares of the medical equipment provider’s stock after selling 53 shares during the period. Lincoln National Corp’s holdings in Intuitive Surgical were worth $859,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Bogart Wealth LLC boosted its position in shares of Intuitive Surgical by 70.1% in the third quarter. Bogart Wealth LLC now owns 148 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 61 shares during the period. Larson Financial Group LLC boosted its position in shares of Intuitive Surgical by 196.1% in the second quarter. Larson Financial Group LLC now owns 151 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 100 shares during the period. MV Capital Management Inc. boosted its position in shares of Intuitive Surgical by 138.9% in the second quarter. MV Capital Management Inc. now owns 172 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 100 shares during the period. JFS Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 82.5% in the second quarter. JFS Wealth Advisors LLC now owns 188 shares of the medical equipment provider’s stock valued at $38,000 after acquiring an additional 85 shares during the period. Finally, Gleason Group Inc. boosted its position in shares of Intuitive Surgical by 111.1% in the third quarter. Gleason Group Inc. now owns 190 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 100 shares during the period. Institutional investors and hedge funds own 81.96% of the company’s stock.
Intuitive Surgical Stock Performance
Shares of NASDAQ:ISRG opened at $257.98 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $180.07 and a twelve month high of $308.97. The firm has a market cap of $91.17 billion, a PE ratio of 68.07, a price-to-earnings-growth ratio of 4.90 and a beta of 1.36. The business has a fifty day moving average of $264.91 and a 200-day moving average of $234.18.
Insider Buying and Selling
In related news, Director Amal M. Johnson sold 6,375 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 8th. The stock was sold at an average price of $239.36, for a total value of $1,525,920.00. Following the completion of the sale, the director now directly owns 11,224 shares in the company, valued at $2,686,576.64. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, EVP Myriam Curet sold 8,000 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 1st. The stock was sold at an average price of $250.06, for a total value of $2,000,480.00. Following the completion of the sale, the executive vice president now directly owns 217 shares in the company, valued at $54,263.02. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Amal M. Johnson sold 6,375 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 8th. The stock was sold at an average price of $239.36, for a total value of $1,525,920.00. Following the completion of the sale, the director now owns 11,224 shares of the company’s stock, valued at $2,686,576.64. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on ISRG shares. Barclays increased their price objective on Intuitive Surgical from $235.00 to $298.00 in a research report on Wednesday, January 4th. StockNews.com initiated coverage on Intuitive Surgical in a research report on Wednesday, October 12th. They issued a “hold” rating for the company. Deutsche Bank Aktiengesellschaft raised their target price on Intuitive Surgical from $205.00 to $230.00 and gave the stock a “hold” rating in a research report on Thursday, October 20th. BTIG Research raised their target price on Intuitive Surgical from $247.00 to $316.00 and gave the stock a “buy” rating in a research report on Monday, December 5th. Finally, Morgan Stanley raised their target price on Intuitive Surgical from $235.00 to $290.00 and gave the stock an “equal weight” rating in a research report on Friday, January 6th. Seven research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $280.53.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Featured Articles
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.